Developmental and cell type-specific expression of thyroid hormone transporters in the mouse brain and in primary brain cells

GLIA

Volumn 59, Issue 3, 2011, Pages 463-471

  Braun, Doreen ^a   Kinne, Anita ^a   Brauer, Anja U ^a   Sapin, Remy ^b   Klein, Marc O ^c   Köhrle, Josef ^a   Wirth, Eva K ^a   Schweizer, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Astrocyte; Blood brain barrier; Development; Microglia; Neuron

Indexed keywords

L TYPE AMINO ACID TRANSPORTER 1; L TYPE AMINO ACID TRANSPORTER 2; MEMBRANE PROTEIN; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTER 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CELL CULTURE; CELL LINE; CONTROLLED STUDY; HUMAN; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MYELINATION; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD98 LIGHT CHAINS; ASTROCYTES; BRAIN; CELL LINE; CELLS, CULTURED; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PROTEIN TRANSPORT; THYROXINE; TRIIODOTHYRONINE;

EID: 78951470785     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21116     Document Type: Article

References (47)

1. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120: 1097-1108.
2. Blasig IE, Giese H, Schroeter ML, Sporbert A, Utepbergenov DI, Buchwalow IB, Neubert K, Schonfelder G, Freyer D, Schimke I, Siems WE, Paul M, Haseloff RF, Blasig R. 2001. NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. Microvasc Res 62: 114-127.
3. Blondeau JP, Beslin A, Chantoux F, Francon J. 1993. Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 60: 1407-1413.
4. Braun D, Wirth EK, Schweizer U. 2010. Thyroid hormone transporters in the brain. Rev Neurosci 21: 173-186.
5. Bröer S, Bröer A, Hansen JT, Bubb WA, Balcar VJ, Nasrallah FA, Garner B, Rae C. 2007. Alanine metabolism, transport, and cycling in the brain. J Neurochem 102: 1758-1770.
6. Chantoux F, Blondeau JP, Francon J. 1995. Characterization of the thyroid hormone transport system of cerebrocortical rat neurons in primary culture. J Neurochem 65: 2549-2554.
7. Christensen HN. 1975.Current topics in membranes and transport, Vol. 6. New York: Academic Press.
8. Crantz FR, Larsen PR. 1980. Rapid thyroxine to 3, 5, 3'-triiodothyronine conversion and nuclear 3, 5, 3'-triiodothyronine binding in rat cerebral cortex and cerebellum. J Clin Invest 65: 935-938.
9. Dratman MB, Crutchfield FL, Schoenhoff MB. 1991. Transport of iodothyronines from bloodstream to brain: Contributions by blood:brain and choroid plexus:cerebrospinal fluid barriers. Brain Res 554: 229-236.
10. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S. 2004. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74: 168-175.
11. Feutz AC, Pham-Dinh D, Allinquant B, Miehe M, Ghandour MS. 2001. An immortalized jimpy oligodendrocyte cell line: Defects in cell cycle and cAMP pathway. Glia 34: 241-252.
12. Francon J, Chantoux F, Blondeau JP. 1989. Carrier-mediated transport of thyroid hormones into rat glial cells in primary culture. J Neurochem 53: 1456-1463.
13. Freitas BC, Gereben B, Castillo M, Kallo I, Zeold A, Egri P, Liposits Z, Zavacki AM, Maciel RM, Jo S, Singru P, Sanchez E, Lechan RM, Bianco AC. 2010. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120: 2206-2217.
14. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G, Visser TJ. 2001. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 142: 4339-4348.
15. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. 2003. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40128-40135.
16. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ. 2004. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364: 1435-1437.
17. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ. 2008. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22: 1357-1369.
18. Ghandour MS, Feutz AC, Jalabi W, Taleb O, Bessert D, Cypher M, Carlock L, Skoff RP. 2002. Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes. Glia 40: 300-311.
19. Guadano-Ferraz A, Escamez MJ, Rausell E, Bernal J. 1999. Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci 19: 3430-3439.
20. Hagenbuch B. 2007. Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 21: 209-221.
21. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. 2001. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 22: 451-476.
22. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K. 2005. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146: 1701-1706.
23. Holden KR, Zuniga OF, May MM, Su H, Molinero MR, Rogers RC, Schwartz CE. 2005. X-linked MCT8 gene mutations: Characterization of the pediatric neurologic phenotype. J Child Neurol 20: 852-857.
24. Kinne A, Kleinau G, Hoefig CS, Grüters A, Köhrle J, Krause G, Schweizer U. 2010. Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. J Biol Chem 285: 28054-28063.
25. Kinne A, Roth S, Biebermann H, Köhrle J, Grüters A, Schweizer U. 2009. Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent. J Mol Endocrinol 43: 263-271.
26. Köhrle J. 2007. Thyroid hormone transporters in health and disease: Advances in thyroid hormone deiodination. Best Pract Res Clin Endocrinol Metab 21: 173-191.
27. Lechan RM, Fekete C. 2005. Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15: 883-897.
28. Leonard JL, Kaplan MM, Visser TJ, Silva JE, Larsen PR. 1981. Cerebral cortex responds rapidly to thyroid hormones. Science 214: 571-573.
29. Morte B, Manzano J, Scanlan T, Vennstrom B, Bernal J. 2002. Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci USA 99: 3985-3989.
30. Namba N, Etani Y, Kitaoka T, Nakamoto Y, Nakacho M, Bessho K, Miyoshi Y, Mushiake S, Mohri I, Arai H, Taniike M, Ozono K. 2008. Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter. Eur J Pediatr 167: 785-791.
31. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, Lloberas J, Zorzano A, Palacin M. 1999. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274: 19738-19744.
32. Ritchie JW, Peter GJ, Shi YB, Taylor PM. 1999. Thyroid hormone transport by 4F2hc-IU12 heterodimers expressed in Xenopus oocytes. J Endocrinol 163: R5-R9.
33. Roberts LM, Black DS, Raman C, Woodford K, Zhou M, Haggerty JE, Yan AT, Cwirla SE, Grindstaff KK. 2008a. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155: 423-438.
34. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N. 2008b. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149: 6251-6261.
35. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, Köhrle J. 2003. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397-402.
36. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE. 2005. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77: 41-53.
37. Schweizer U, Weitzel JM, Schomburg L. 2008. Think globally: Act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol 289: 1-9.
38. Streckfuss F, Hamann I, Schomburg L, Michaelis M, Sapin R, Klein MO, Köhrle J, Schweizer U. 2005. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochem Biophys Res Commun 337: 739-745.
39. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y. 2003. Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: High affinity transporter for thyroxine. J Biol Chem 278: 43489-43495.
40. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H. 2007. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117: 627-635.
41. van Doorn J, van der Heide D, Roelfsema F. 1983. Sources and quantity of 3, 5, 3'-triiodothyronine in several tissues of the rat. J Clin Invest 72: 1778-1792.
42. Visser WE, Friesema EC, Jansen J, Visser TJ. 2007. Thyroid hormone transport by monocarboxylate transporters. Best Pract Res Clin Endocrinol Metab 21: 223-236.
43. Visser WE, Jansen J, Friesema EC, Kester MH, Mancilla E, Lundgren J, van der Knaap MS, Lunsing RJ, Brouwer OF, Visser TJ. 2009. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations. Hum Mutat 30: 29-38.
44. Westholm DE, Rumbley JN, Salo DR, Rich TP, Anderson GW. 2008. Organic anion-transporting polypeptides at the blood-brain and blood-cerebrospinal fluid barriers. Curr Top Dev Biol 80: 135-170.
45. Wirth EK, Roth S, Blechschmidt C, Holter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H, Wurst W, Naumann T, Brauer A, de Angelis MH, Köhrle J, Grüters A, Schweizer U. 2009. Neuronal 3', 3, 5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 29: 9439-9449.
46. Zavacki AM, Ying H, Christoffolete MA, Aerts G, So E, Harney JW, Cheng SY, Larsen PR, Bianco AC. 2005. Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 146: 1568-1575.
47. Zoeller RT, Rovet J. 2004. Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings. J Neuroendocrinol 16: 809-818.